Native T1 mapping in transthyretin amyloidosis.

Native T1 mapping in transthyretin amyloidosis.

他のバージョン（1件）を表示する

The aims of the study were to explore the ability of native myocardial T1 mapping by cardiac magnetic resonance to: 1) detect cardiac involvement in patients with transthyretin amyloidosis (ATTR amyloidosis); 2) track the cardiac amyloid burden; and 3) detect early disease.ATTR amyloidosis is an und...

書誌詳細
主要な著者:	Fontana, M, Banypersad, S, Treibel, T, Maestrini, V, Sado, D, White, S, Pica, S, Castelletti, S, Piechnik, S, Robson, M, Gilbertson, J, Rowczenio, D, Hutt, D, Lachmann, H, Wechalekar, A, Whelan, C, Gillmore, J, Hawkins, P, Moon, J
フォーマット:	Journal article
言語:	English
出版事項:	2014

類似資料

Native T1 mapping in transthyretin amyloidosis
著者:: Fontana, M, 等
出版事項: (2014)

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
著者:: Dungu Jason, 等
出版事項: (2012-02-01)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis.
著者:: Karamitsos, T, 等
出版事項: (2012)

Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac Amyloidosis
著者:: Adam Ioannou, 等
出版事項: (2024-02-01)

Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of cardiac amyloidosis
著者:: Ashutosh D. Wechalekar, 等
出版事項: (2011-07-01)

Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease
著者:: Ashutosh D. Wechalekar, 等
出版事項: (2008-02-01)

Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis
著者:: Karamitsos, T, 等
出版事項: (2013)

Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
著者:: Karamitsos, T, 等
出版事項: (2013)

The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis
著者:: Tamer Rezk, 等
出版事項: (2019-07-01)

A prospective study of nutritional status in immunoglobulin light chain amyloidosis
著者:: Prayman T. Sattianayagam, 等
出版事項: (2013-01-01)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis
著者:: Karamitsos Theodoros, 等
出版事項: (2012-02-01)

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
著者:: Faye A. Sharpley, 等
出版事項: (2020-05-01)

Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis.
著者:: Richards, D, 等
出版事項: (2018)

Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.
著者:: Sado, D, 等
出版事項: (2013)

Ethnicity in systemic AL amyloidosis may impact risk stratification
著者:: Jahanzaib Khwaja, 等
出版事項: (2025-01-01)

T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.
著者:: White, S, 等
出版事項: (2013)

T1 mapping for myocardial extracellular volume measurement by CMR: Bolus only versus primed infusion technique
著者:: White, S, 等
出版事項: (2013)

Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib
著者:: Sriram Ravichandran, 等
出版事項: (2021-06-01)

Management of transthyretin amyloidosis
著者:: Adalgisa Condoluci, 等
出版事項: (2021-10-01)

Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience
著者:: Yousuf Razvi, 等
出版事項: (2023-01-01)

Hereditary transthyretin amyloidosis
著者:: T. A. Adyan, 等
出版事項: (2020-01-01)

Native T1 lowering in iron overload and Anderson Fabry disease; a novel and early marker of disease
著者:: Sado Daniel, 等
出版事項: (2013-01-01)

Multiorgan ECV as measured by EQ-MRI in systemic amyloidosis
著者:: Banypersad Sanjay M, 等
出版事項: (2013-01-01)

Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis
著者:: Richa Manwani, 等
出版事項: (2018-04-01)

Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR.
著者:: Fontana, M, 等
出版事項: (2012)

Transthyretin Cardiac Amyloidosis: Underrecognized in the Underrepresented
著者:: Douglas J. Leedy, 等
出版事項: (2023-08-01)

Erratum to: Management of transthyretin amyloidosis
著者:: Swiss Medical Weekly
出版事項: (2021-11-01)

Renal Amyloidosis Associated With 5 Novel Variants in the Fibrinogen A Alpha Chain Protein
著者:: Dorota Rowczenio, 等
出版事項: (2017-05-01)

World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
著者:: Dulce Brito (Chair), 等
出版事項: (2023-10-01)

Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner
著者:: Morie Gertz, 等
出版事項: (2020-09-01)

Coexistence of Light Chain and Transthyretin Cardiac Amyloidosis
著者:: Abhishek Gami, MD, 等
出版事項: (2024-04-01)

Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis
著者:: Sajitha Sachchithanantham, 等
出版事項: (2015-11-01)

Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis
著者:: Hiroki Yamaguchi, 等
出版事項: (2022-03-01)

Specific therapeutic options for transthyretin amyloidosis
著者:: Zoltán Pozsonyi
出版事項: (2024-12-01)

Clinical case of hereditary transthyretin amyloidosis
著者:: N. Spasova, 等
出版事項: (2024-12-01)

Diagnostic algorithm in transthyretin amyloidosis with cardiomyopathy
著者:: Mariana Gospodinova, 等
出版事項: (2020-07-01)

A review of transthyretin cardiac amyloidosis
著者:: Jhawar Nikita, 等
出版事項: (2023-03-01)

Transthyretin Amyloidosis Therapies: Guiding the Future
著者:: Alejandra González-Duarte
出版事項: (2021-01-01)

Modulation of the Mechanisms Driving Transthyretin Amyloidosis
著者:: Filipa Bezerra, 等
出版事項: (2020-12-01)

Disease-Modifying Therapy for Transthyretin Amyloidosis
著者:: Nowell M. Fine, MD, SM
出版事項: (2020-11-01)